Prescient Therapeutics Limited (AU:PTX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Prescient Therapeutics Limited has announced the cessation of 3 million options due to unmet conditions as of September 30, 2024. The options, initially set to expire on December 8, 2025, were discontinued because the required conditions were not satisfied. This update may interest investors tracking the company’s capital structure and future prospects.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.